August 15, 2019 / 8:32 PM / a month ago

Teva settles multibillion-dollar drug kickback case ahead of trial

Teva Pharmaceutical Industries Ltd has agreed on the eve of trial to settle a multibillion-dollar whistleblower lawsuit alleging it paid doctors kickbacks to prescribe its Parkinson’s disease drug Azilect and multiple sclerosis treatment Copaxone.

Teva late on Wednesday said it had reached an agreement-in-principle to resolve a lawsuit in Manhattan federal court by two ex-employees alleging the drugmaker paid doctors to act as speakers at events in order to sway them to prescribe its drugs.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/31DI6aw

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below